Real-time enrollment status for this melanoma clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 11:28 AM UTC
| NCT Number | NCT06743126 |
| Recruiting Status | Recruiting |
| Condition | Melanoma |
| Phase | PHASE3 |
| Target Enrollment | 360 participants |
| Active Locations | 43 sites in the US |
| Sponsor | Immatics US, Inc. |
| Last Updated on CT.gov | August 18, 2026 (2 weeks ago) |
As of September 2, 2026: Clinical trial NCT06743126 is currently recruiting participants. This phase3 study for melanoma is actively seeking new participants at 43 locations across the United States. The study is sponsored by Immatics US, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06743126 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 43 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06743126 was last updated 2 weeks ago (August 18, 2026). HelloStudys verifies this status automatically.